European Nod for HG Nerve Stimulation in Sleep Apnea

An implantable hypoglossal nerve stimulation system will be able to be implanted for the treatment of obstructive sleep apnea. The neurotransmitter, when activated, monitors the patient’s breathing, activating the neurostimulator as needed. This stimulation delivers therapy to the hypoglossal nerve thus ensuring airway passage during sleep.

October 27, 2011 — The European Commission has approved an implantable hypoglossal nerve stimulation (HGNS) system (Apnex Medical, Inc), granting the device the Conformité Européenne Mark for the treatment of obstructive sleep apnea (OSA).

Two clinical studies conducted in the US and Australia revealed significant reductions in OSA and increased quality of life. Further studies are now allowed in Europe for sleep apnea patients.

Click here to visit the original source of this post

Share
This entry was posted in Obstructive Sleep Apnea, Sleep Apnea Medical News, Sleep Apnea News, Sleep Apnea Symptoms, Sleep Disorders. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *